PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$161M
This Quarter Return
+23.34%
1 Year Return
+58.57%
3 Year Return
+760.98%
5 Year Return
–
10 Year Return
–
AUM
$168M
AUM Growth
+$168M
(+30%)
Cap. Flow
+$4.92M
Cap. Flow
% of AUM
2.92%
Top 10 Holdings %
Top 10 Hldgs %
99.46%
Holding
12
New
2
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
ZBIO
Zenas BioPharma, Inc. Common Stock
ZBIO
|
$11M |
| 2 |
BIOA
BioAge Labs, Inc. Common Stock
BIOA
|
$11M |
| 3 |
Arcutis Biotherapeutics
ARQT
|
$738K |
Top Sells
| 1 |
Vaxcyte
PCVX
|
$17.5M |
| 2 |
Aligos Therapeutics
ALGS
|
$260K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vaxcyte
PCVX
$4B
| $73.1M | 43.38% | 639,539 -153,497 | -19% | -$17.5M |
|
|
INZY
2
DELISTED
Inozyme Pharma
INZY
| $23.5M | 13.95% | 4,494,851 | – | – |
|
|
3
Arcutis Biotherapeutics
ARQT
$1.86B
| $19.7M | 11.71% | 2,120,508 +79,400 | +4% | +$738K |
|
4
Oculis Holding
OCS
$844M
| $19.6M | 11.61% | 1,595,918 | – | – |
|
|
ZBIO
5
Zenas BioPharma, Inc. Common Stock
ZBIO
$674M
| $11M | 6.54% | +650,695 | New | +$11M |
|
|
BIOA
6
BioAge Labs, Inc. Common Stock
BIOA
$177M
| $11M | 6.51% | +527,647 | New | +$11M |
|
|
EXAI
7
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $3.76M | 2.23% | 770,500 | – | – |
|
8
Rallybio
RLYB
$22.4M
| $2.81M | 1.67% | 2,404,644 | – | – |
|
|
VIGL
9
DELISTED
Vigil Neuroscience
VIGL
| $1.91M | 1.13% | 560,595 | – | – |
|
10
Bolt Biotherapeutics
BOLT
$9.85M
| $1.23M | 0.73% | 1,891,467 | – | – |
|
11
IO Biotech
IOBT
$104M
| $907K | 0.54% | 864,197 | – | – |
|
|
12
Aligos Therapeutics
ALGS
$73.3M
| – | – | -743,215 | Closed | -$260K |
|